ID   NICA_HUMAN              Reviewed;         709 AA.
AC   Q92542; Q5T207; Q5T208; Q86VV5;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2001, sequence version 2.
DT   28-JUN-2023, entry version 205.
DE   RecName: Full=Nicastrin;
DE   Flags: Precursor;
GN   Name=NCSTN; Synonyms=KIAA0253; ORFNames=UNQ1874/PRO4317;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), IDENTIFICATION BY MASS
RP   SPECTROMETRY, FUNCTION, IDENTIFICATION IN THE GAMMA-SECRETASE COMPLEX,
RP   INTERACTION WITH PSEN1 AND PSEN2, SUBCELLULAR LOCATION, GLYCOSYLATION,
RP   TISSUE SPECIFICITY, AND MUTAGENESIS OF 336-ASP-TYR-337.
RC   TISSUE=Embryonic kidney;
RX   PubMed=10993067; DOI=10.1038/35024009;
RA   Yu G., Nishimura M., Arawaka S., Levitan D., Zhang L., Tandon A.,
RA   Song Y.-Q., Rogaeva E., Chen F., Kawarai T., Supala A., Levesque L., Yu H.,
RA   Yang D.-S., Holmes E., Milman P., Liang Y., Zhang D.M., Xu D.H., Sato C.,
RA   Rogaev E., Smith M., Janus C., Zhang Y., Aebersold R., Farrer L.S.,
RA   Sorbi S., Bruni A., Fraser P.E., St George-Hyslop P.H.;
RT   "Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction
RT   and betaAPP processing.";
RL   Nature 407:48-54(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2-709 (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=9039502; DOI=10.1093/dnares/3.5.321;
RA   Nagase T., Seki N., Ishikawa K., Ohira M., Kawarabayasi Y., Ohara O.,
RA   Tanaka A., Kotani H., Miyajima N., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. VI. The
RT   coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of
RT   cDNA clones from cell line KG-1 and brain.";
RL   DNA Res. 3:321-329(1996).
RN   [8]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=11396676; DOI=10.1046/j.1440-1789.2001.00378.x;
RA   Satoh J., Kuroda Y.;
RT   "Nicastrin, a key regulator of presenilin function, is expressed
RT   constitutively in human neural cell lines.";
RL   Neuropathology 21:115-122(2001).
RN   [9]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=12643545; DOI=10.1021/pr025562r;
RA   Basrur V., Yang F., Kushimoto T., Higashimoto Y., Yasumoto K., Valencia J.,
RA   Muller J., Vieira W.D., Watabe H., Shabanowitz J., Hearing V.J., Hunt D.F.,
RA   Appella E.;
RT   "Proteomic analysis of early melanosomes: identification of novel
RT   melanosomal proteins.";
RL   J. Proteome Res. 2:69-79(2003).
RN   [10]
RP   COMPONENT OF A GAMMA-SECRETASE COMPLEX WITH PEN2; PSEN1/PSEN2 AND APH1A.
RX   PubMed=12740439; DOI=10.1073/pnas.1037392100;
RA   Kimberly W.T., LaVoie M.J., Ostaszewski B.L., Ye W., Wolfe M.S.,
RA   Selkoe D.J.;
RT   "Gamma-secretase is a membrane protein complex comprised of presenilin,
RT   nicastrin, Aph-1, and Pen-2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:6382-6387(2003).
RN   [11]
RP   ENZYME ACTIVITY OF A GAMMA-SECRETASE COMPLEX.
RX   PubMed=12679784; DOI=10.1038/ncb960;
RA   Edbauer D., Winkler E., Regula J.T., Pesold B., Steiner H., Haass C.;
RT   "Reconstitution of gamma-secretase activity.";
RL   Nat. Cell Biol. 5:486-488(2003).
RN   [12]
RP   GLYCOSYLATION AT ASN-387.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [13]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H., Mangini N.J.,
RA   Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R., Yamagishi S.,
RA   Shabanowitz J., Hearing V.J., Wu C., Appella E., Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-45; ASN-187 AND ASN-387.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [15]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-612.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-linked
RT   cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [18]
RP   STRUCTURE BY ELECTRON MICROSCOPY (5.40 ANGSTROMS), FUNCTION, SUBCELLULAR
RP   LOCATION, TOPOLOGY, SUBUNIT, DISULFIDE BONDS, AND GLYCOSYLATION.
RX   PubMed=25043039; DOI=10.1038/nature13567;
RA   Lu P., Bai X.C., Ma D., Xie T., Yan C., Sun L., Yang G., Zhao Y., Zhou R.,
RA   Scheres S.H., Shi Y.;
RT   "Three-dimensional structure of human gamma-secretase.";
RL   Nature 512:166-170(2014).
RN   [19]
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.00 ANGSTROMS), DISULFIDE BONDS,
RP   SUBCELLULAR LOCATION, TOPOLOGY, AND SUBUNIT.
RX   PubMed=26623517; DOI=10.7554/elife.11182;
RA   Bai X.C., Rajendra E., Yang G., Shi Y., Scheres S.H.;
RT   "Sampling the conformational space of the catalytic subunit of human gamma-
RT   secretase.";
RL   Elife 4:0-0(2015).
RN   [20]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.40 ANGSTROMS), FUNCTION, SUBCELLULAR
RP   LOCATION, TOPOLOGY, SUBUNIT, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-45;
RP   ASN-55; ASN-187; ASN-264; ASN-387; ASN-435; ASN-464; ASN-506; ASN-530;
RP   ASN-562 AND ASN-573.
RX   PubMed=26280335; DOI=10.1038/nature14892;
RA   Bai X.C., Yan C., Yang G., Lu P., Ma D., Sun L., Zhou R., Scheres S.H.,
RA   Shi Y.;
RT   "An atomic structure of human gamma-secretase.";
RL   Nature 525:212-217(2015).
RN   [21]
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.40 ANGSTROMS) OF 42-665, DISULFIDE
RP   BONDS, SUBCELLULAR LOCATION, TOPOLOGY, AND SUBUNIT.
RX   PubMed=25918421; DOI=10.1073/pnas.1506242112;
RA   Sun L., Zhao L., Yang G., Yan C., Zhou R., Zhou X., Xie T., Zhao Y., Wu S.,
RA   Li X., Shi Y.;
RT   "Structural basis of human gamma-secretase assembly.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:6003-6008(2015).
RN   [22]
RP   STRUCTURE BY NMR OF 664-709, AND SUBCELLULAR LOCATION.
RX   PubMed=26776682; DOI=10.1038/srep19522;
RA   Li Y., Liew L.S., Li Q., Kang C.;
RT   "Structure of the transmembrane domain of human nicastrin-a component of
RT   gamma-secretase.";
RL   Sci. Rep. 6:19522-19522(2016).
RN   [23] {ECO:0007744|PDB:6IDF}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.70 ANGSTROMS) IN COMPLEX WITH NOTCH1;
RP   PSENEN; APH1A AND PSEN1, FUNCTION, SUBUNIT, TOPOLOGY, GLYCOSYLATION AT
RP   ASN-45; ASN-55; ASN-187; ASN-264; ASN-387; ASN-435; ASN-464; ASN-506;
RP   ASN-530; ASN-562 AND ASN-573, DISULFIDE BOND, AND MUTAGENESIS OF TRP-653.
RX   PubMed=30598546; DOI=10.1038/s41586-018-0813-8;
RA   Yang G., Zhou R., Zhou Q., Guo X., Yan C., Ke M., Lei J., Shi Y.;
RT   "Structural basis of Notch recognition by human gamma-secretase.";
RL   Nature 565:192-197(2019).
RN   [24] {ECO:0007744|PDB:6IYC}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.60 ANGSTROMS) IN COMPLEX WITH APP CHAIN
RP   C83; PSENEN; APH1A AND PSEN1, FUNCTION, SUBUNIT, TOPOLOGY, GLYCOSYLATION AT
RP   ASN-45; ASN-55; ASN-187; ASN-264; ASN-387; ASN-435; ASN-464; ASN-506;
RP   ASN-530; ASN-562; ASN-573 AND ASN-580, AND DISULFIDE BOND.
RX   PubMed=30630874; DOI=10.1126/science.aaw0930;
RA   Zhou R., Yang G., Guo X., Zhou Q., Lei J., Shi Y.;
RT   "Recognition of the amyloid precursor protein by human gamma-secretase.";
RL   Science 0:0-0(2019).
RN   [25]
RP   INVOLVEMENT IN ACNINV1.
RX   PubMed=20929727; DOI=10.1126/science.1196284;
RA   Wang B., Yang W., Wen W., Sun J., Su B., Liu B., Ma D., Lv D., Wen Y.,
RA   Qu T., Chen M., Sun M., Shen Y., Zhang X.;
RT   "Gamma-secretase gene mutations in familial acne inversa.";
RL   Science 330:1065-1065(2010).
RN   [26]
RP   INVOLVEMENT IN ACNINV1.
RX   PubMed=21430701; DOI=10.1038/jid.2011.62;
RA   Liu Y., Gao M., Lv Y.M., Yang X., Ren Y.Q., Jiang T., Zhang X., Guo B.R.,
RA   Li M., Zhang Q., Zhang P., Zhou F.S., Chen G., Yin X.Y., Zuo X.B.,
RA   Sun L.D., Zheng X.D., Zhang S.M., Liu J.J., Zhou Y., Li Y.R., Wang J.,
RA   Wang J., Yang H.M., Yang S., Li R.Q., Zhang X.J.;
RT   "Confirmation by exome sequencing of the pathogenic role of NCSTN mutations
RT   in acne inversa (hidradenitis suppurativa).";
RL   J. Invest. Dermatol. 131:1570-1572(2011).
RN   [27]
RP   VARIANT ACNINV1 ARG-211.
RX   PubMed=21495993; DOI=10.1111/j.1365-2133.2011.10372.x;
RA   Li C.R., Jiang M.J., Shen D.B., Xu H.X., Wang H.S., Yao X., Zhang Y.,
RA   Zhou W.Q., Wang B.;
RT   "Two novel mutations of the nicastrin gene in Chinese patients with acne
RT   inversa.";
RL   Br. J. Dermatol. 165:415-418(2011).
CC   -!- FUNCTION: Essential subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral membrane proteins such as Notch receptors and APP (amyloid-
CC       beta precursor protein) (PubMed:10993067, PubMed:12679784,
CC       PubMed:25043039, PubMed:26280335, PubMed:30598546, PubMed:30630874).
CC       The gamma-secretase complex plays a role in Notch and Wnt signaling
CC       cascades and regulation of downstream processes via its role in
CC       processing key regulatory proteins, and by regulating cytosolic CTNNB1
CC       levels. {ECO:0000269|PubMed:10993067, ECO:0000269|PubMed:12679784,
CC       ECO:0000269|PubMed:25043039, ECO:0000269|PubMed:26280335,
CC       ECO:0000269|PubMed:30598546, ECO:0000269|PubMed:30630874}.
CC   -!- SUBUNIT: Component of the gamma-secretase complex (PubMed:10993067,
CC       PubMed:30598546, PubMed:30630874). The functional gamma-secretase
CC       complex is composed of at least four polypeptides: a presenilin
CC       homodimer (PSEN1 or PSEN2), nicastrin (NCSTN), APH1 (APH1A or APH1B)
CC       and PSENEN/PEN2 (PubMed:12740439, PubMed:25043039, PubMed:26623517,
CC       PubMed:26280335, PubMed:25918421, PubMed:30598546, PubMed:30630874).
CC       Binds to proteolytic processed C-terminal fragments C83 and C99 of the
CC       amyloid precursor protein (APP) (PubMed:10993067, PubMed:30630874).
CC       Interacts with PSEN1 and PSEN2 (PubMed:10993067).
CC       {ECO:0000269|PubMed:10993067, ECO:0000269|PubMed:12740439,
CC       ECO:0000269|PubMed:25043039, ECO:0000269|PubMed:25918421,
CC       ECO:0000269|PubMed:26280335, ECO:0000269|PubMed:26623517,
CC       ECO:0000269|PubMed:30598546, ECO:0000269|PubMed:30630874}.
CC   -!- INTERACTION:
CC       Q92542; Q96BI3: APH1A; NbExp=4; IntAct=EBI-998440, EBI-2606935;
CC       Q92542; P35613: BSG; NbExp=6; IntAct=EBI-998440, EBI-750709;
CC       Q92542; P49768: PSEN1; NbExp=6; IntAct=EBI-998440, EBI-297277;
CC       Q92542; PRO_0000025592 [P49768]: PSEN1; NbExp=2; IntAct=EBI-998440, EBI-2606356;
CC       Q92542; Q9NZ42: PSENEN; NbExp=4; IntAct=EBI-998440, EBI-998468;
CC       Q92542; P49755: TMED10; NbExp=5; IntAct=EBI-998440, EBI-998422;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:10993067,
CC       ECO:0000269|PubMed:25043039, ECO:0000269|PubMed:25918421,
CC       ECO:0000269|PubMed:26280335, ECO:0000269|PubMed:26623517,
CC       ECO:0000269|PubMed:26776682}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:25043039, ECO:0000269|PubMed:25918421,
CC       ECO:0000269|PubMed:26280335, ECO:0000269|PubMed:26623517,
CC       ECO:0000269|PubMed:30598546, ECO:0000269|PubMed:30630874}. Cytoplasmic
CC       vesicle membrane {ECO:0000269|PubMed:10993067}; Single-pass type I
CC       membrane protein {ECO:0000269|PubMed:25043039,
CC       ECO:0000269|PubMed:25918421, ECO:0000269|PubMed:26280335,
CC       ECO:0000269|PubMed:26623517, ECO:0000269|PubMed:30598546,
CC       ECO:0000269|PubMed:30630874}. Melanosome {ECO:0000269|PubMed:12643545,
CC       ECO:0000269|PubMed:17081065}. Note=Identified by mass spectrometry in
CC       melanosome fractions from stage I to stage IV.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q92542-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92542-2; Sequence=VSP_008385, VSP_008386;
CC   -!- TISSUE SPECIFICITY: Detected in brain (at protein level)
CC       (PubMed:10993067). Widely expressed (PubMed:11396676).
CC       {ECO:0000269|PubMed:10993067, ECO:0000269|PubMed:11396676}.
CC   -!- INDUCTION: Constitutively expressed in neural cells.
CC       {ECO:0000269|PubMed:11396676}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:10993067,
CC       ECO:0000269|PubMed:25043039, ECO:0000269|PubMed:26280335,
CC       ECO:0000269|PubMed:30598546, ECO:0000269|PubMed:30630874}.
CC   -!- DISEASE: Acne inversa, familial, 1 (ACNINV1) [MIM:142690]: A chronic
CC       relapsing inflammatory disease of the hair follicles characterized by
CC       recurrent draining sinuses, painful skin abscesses, and disfiguring
CC       scars. Manifestations typically appear after puberty.
CC       {ECO:0000269|PubMed:20929727, ECO:0000269|PubMed:21430701,
CC       ECO:0000269|PubMed:21495993}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the nicastrin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF240468; AAG11412.1; -; mRNA.
DR   EMBL; AY359120; AAQ89478.1; -; mRNA.
DR   EMBL; AK314764; BAG37302.1; -; mRNA.
DR   EMBL; AL445230; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW52720.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW52721.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW52722.1; -; Genomic_DNA.
DR   EMBL; BC047621; AAH47621.1; -; mRNA.
DR   EMBL; D87442; BAA13383.1; -; mRNA.
DR   CCDS; CCDS1203.1; -. [Q92542-1]
DR   RefSeq; NP_001277113.1; NM_001290184.1. [Q92542-2]
DR   RefSeq; NP_001277115.1; NM_001290186.1.
DR   RefSeq; NP_056146.1; NM_015331.2. [Q92542-1]
DR   PDB; 2N7Q; NMR; -; A=664-709.
DR   PDB; 2N7R; NMR; -; A=664-709.
DR   PDB; 4UIS; EM; 4.40 A; A=42-665.
DR   PDB; 5A63; EM; 3.40 A; A=1-709.
DR   PDB; 5FN2; EM; 4.20 A; A=1-709.
DR   PDB; 5FN3; EM; 4.10 A; A=1-709.
DR   PDB; 5FN4; EM; 4.00 A; A=1-709.
DR   PDB; 5FN5; EM; 4.30 A; A=1-709.
DR   PDB; 6IDF; EM; 2.70 A; A=1-709.
DR   PDB; 6IYC; EM; 2.60 A; A=1-709.
DR   PDB; 6LQG; EM; 3.10 A; A=1-709.
DR   PDB; 6LR4; EM; 3.00 A; A=1-709.
DR   PDB; 7C9I; EM; 3.10 A; A=1-709.
DR   PDB; 7D8X; EM; 2.60 A; A=1-709.
DR   PDB; 7Y5T; EM; 2.90 A; A=1-709.
DR   PDB; 7Y5X; EM; 3.00 A; A=1-709.
DR   PDB; 7Y5Z; EM; 3.40 A; A=1-709.
DR   PDBsum; 2N7Q; -.
DR   PDBsum; 2N7R; -.
DR   PDBsum; 4UIS; -.
DR   PDBsum; 5A63; -.
DR   PDBsum; 5FN2; -.
DR   PDBsum; 5FN3; -.
DR   PDBsum; 5FN4; -.
DR   PDBsum; 5FN5; -.
DR   PDBsum; 6IDF; -.
DR   PDBsum; 6IYC; -.
DR   PDBsum; 6LQG; -.
DR   PDBsum; 6LR4; -.
DR   PDBsum; 7C9I; -.
DR   PDBsum; 7D8X; -.
DR   PDBsum; 7Y5T; -.
DR   PDBsum; 7Y5X; -.
DR   PDBsum; 7Y5Z; -.
DR   AlphaFoldDB; Q92542; -.
DR   SMR; Q92542; -.
DR   BioGRID; 116961; 180.
DR   ComplexPortal; CPX-2176; Gamma-secretase complex, APH1A-PSEN1 variant.
DR   ComplexPortal; CPX-4231; Gamma-secretase complex, APH1A-PSEN2 variant.
DR   ComplexPortal; CPX-4232; Gamma-secretase complex, APH1B-PSEN2 variant.
DR   ComplexPortal; CPX-4233; Gamma-secretase complex, APH1B-PSEN1 variant.
DR   CORUM; Q92542; -.
DR   DIP; DIP-36336N; -.
DR   IntAct; Q92542; 88.
DR   MINT; Q92542; -.
DR   STRING; 9606.ENSP00000294785; -.
DR   BindingDB; Q92542; -.
DR   ChEMBL; CHEMBL3418; -.
DR   GlyConnect; 1567; 6 N-Linked glycans (7 sites).
DR   GlyCosmos; Q92542; 17 sites, 6 glycans.
DR   GlyGen; Q92542; 24 sites, 7 N-linked glycans (8 sites), 1 O-linked glycan (5 sites).
DR   iPTMnet; Q92542; -.
DR   PhosphoSitePlus; Q92542; -.
DR   SwissPalm; Q92542; -.
DR   BioMuta; NCSTN; -.
DR   DMDM; 12231037; -.
DR   EPD; Q92542; -.
DR   jPOST; Q92542; -.
DR   MassIVE; Q92542; -.
DR   MaxQB; Q92542; -.
DR   PaxDb; Q92542; -.
DR   PeptideAtlas; Q92542; -.
DR   ProteomicsDB; 75302; -. [Q92542-1]
DR   ProteomicsDB; 75303; -. [Q92542-2]
DR   TopDownProteomics; Q92542-2; -. [Q92542-2]
DR   Antibodypedia; 20490; 585 antibodies from 44 providers.
DR   DNASU; 23385; -.
DR   Ensembl; ENST00000294785.10; ENSP00000294785.5; ENSG00000162736.18. [Q92542-1]
DR   GeneID; 23385; -.
DR   KEGG; hsa:23385; -.
DR   MANE-Select; ENST00000294785.10; ENSP00000294785.5; NM_015331.3; NP_056146.1.
DR   UCSC; uc001fvx.4; human. [Q92542-1]
DR   AGR; HGNC:17091; -.
DR   CTD; 23385; -.
DR   DisGeNET; 23385; -.
DR   GeneCards; NCSTN; -.
DR   HGNC; HGNC:17091; NCSTN.
DR   HPA; ENSG00000162736; Low tissue specificity.
DR   MalaCards; NCSTN; -.
DR   MIM; 142690; phenotype.
DR   MIM; 605254; gene.
DR   neXtProt; NX_Q92542; -.
DR   OpenTargets; ENSG00000162736; -.
DR   Orphanet; 387; NON RARE IN EUROPE: Hidradenitis suppurativa.
DR   PharmGKB; PA142671271; -.
DR   VEuPathDB; HostDB:ENSG00000162736; -.
DR   eggNOG; KOG2657; Eukaryota.
DR   GeneTree; ENSGT00390000014633; -.
DR   HOGENOM; CLU_024257_0_0_1; -.
DR   InParanoid; Q92542; -.
DR   OMA; NSYGSEF; -.
DR   OrthoDB; 1330770at2759; -.
DR   PhylomeDB; Q92542; -.
DR   TreeFam; TF317086; -.
DR   PathwayCommons; Q92542; -.
DR   Reactome; R-HSA-1251985; Nuclear signaling by ERBB4.
DR   Reactome; R-HSA-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-HSA-193692; Regulated proteolysis of p75NTR.
DR   Reactome; R-HSA-205043; NRIF signals cell death from the nucleus.
DR   Reactome; R-HSA-2122948; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-2979096; NOTCH2 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-HSA-3928665; EPH-ephrin mediated repulsion of cells.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-9013507; NOTCH3 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-HSA-9013700; NOTCH4 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-HSA-9017802; Noncanonical activation of NOTCH3.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   SignaLink; Q92542; -.
DR   SIGNOR; Q92542; -.
DR   BioGRID-ORCS; 23385; 43 hits in 1155 CRISPR screens.
DR   ChiTaRS; NCSTN; human.
DR   GeneWiki; Nicastrin; -.
DR   GenomeRNAi; 23385; -.
DR   Pharos; Q92542; Tbio.
DR   PRO; PR:Q92542; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q92542; protein.
DR   Bgee; ENSG00000162736; Expressed in stromal cell of endometrium and 198 other tissues.
DR   ExpressionAtlas; Q92542; baseline and differential.
DR   Genevisible; Q92542; HS.
DR   GO; GO:0035577; C:azurophil granule membrane; TAS:Reactome.
DR   GO; GO:0005769; C:early endosome; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HGNC-UCL.
DR   GO; GO:0010008; C:endosome membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0070765; C:gamma-secretase complex; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HGNC-UCL.
DR   GO; GO:0005765; C:lysosomal membrane; HDA:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HGNC-UCL.
DR   GO; GO:0042734; C:presynaptic membrane; IEA:Ensembl.
DR   GO; GO:0042383; C:sarcolemma; IEA:Ensembl.
DR   GO; GO:0008021; C:synaptic vesicle; IEA:Ensembl.
DR   GO; GO:0042500; F:aspartic endopeptidase activity, intramembrane cleaving; IEA:Ensembl.
DR   GO; GO:0051117; F:ATPase binding; IPI:ARUK-UCL.
DR   GO; GO:0070851; F:growth factor receptor binding; IPI:ARUK-UCL.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; IMP:ARUK-UCL.
DR   GO; GO:0030534; P:adult behavior; IEA:Ensembl.
DR   GO; GO:0042983; P:amyloid precursor protein biosynthetic process; IEA:Ensembl.
DR   GO; GO:0042987; P:amyloid precursor protein catabolic process; IDA:ARUK-UCL.
DR   GO; GO:0042982; P:amyloid precursor protein metabolic process; IDA:UniProtKB.
DR   GO; GO:0034205; P:amyloid-beta formation; IDA:ARUK-UCL.
DR   GO; GO:0071277; P:cellular response to calcium ion; IEA:Ensembl.
DR   GO; GO:0022010; P:central nervous system myelination; IEA:Ensembl.
DR   GO; GO:0021549; P:cerebellum development; IEA:Ensembl.
DR   GO; GO:0007212; P:dopamine receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0050673; P:epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0007215; P:glutamate receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0007611; P:learning or memory; IEA:Ensembl.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; IDA:HGNC-UCL.
DR   GO; GO:0031293; P:membrane protein intracellular domain proteolysis; IDA:ComplexPortal.
DR   GO; GO:0002262; P:myeloid cell homeostasis; IEA:Ensembl.
DR   GO; GO:0051402; P:neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0007220; P:Notch receptor processing; IDA:ARUK-UCL.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0042986; P:positive regulation of amyloid precursor protein biosynthetic process; IEA:Ensembl.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; IDA:HGNC-UCL.
DR   GO; GO:0010950; P:positive regulation of endopeptidase activity; IMP:ARUK-UCL.
DR   GO; GO:0016485; P:protein processing; IDA:HGNC-UCL.
DR   GO; GO:0006508; P:proteolysis; NAS:UniProtKB.
DR   GO; GO:1900271; P:regulation of long-term synaptic potentiation; IEA:Ensembl.
DR   GO; GO:1990926; P:short-term synaptic potentiation; IEA:Ensembl.
DR   GO; GO:0042098; P:T cell proliferation; IEA:Ensembl.
DR   CDD; cd03881; M28_Nicastrin; 1.
DR   Gene3D; 3.40.630.10; Zn peptidases; 1.
DR   InterPro; IPR041084; Ncstrn_small.
DR   InterPro; IPR008710; Nicastrin.
DR   PANTHER; PTHR21092; NICASTRIN; 1.
DR   PANTHER; PTHR21092:SF0; NICASTRIN; 1.
DR   Pfam; PF18266; Ncstrn_small; 1.
DR   Pfam; PF05450; Nicastrin; 1.
DR   SUPFAM; SSF53187; Zn-dependent exopeptidases; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasmic vesicle; Disease variant;
KW   Disulfide bond; Glycoprotein; Membrane; Notch signaling pathway;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..33
FT                   /evidence="ECO:0000255"
FT   CHAIN           34..709
FT                   /note="Nicastrin"
FT                   /id="PRO_0000019681"
FT   TOPO_DOM        34..669
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305|PubMed:26280335,
FT                   ECO:0000305|PubMed:26776682"
FT   TRANSMEM        670..690
FT                   /note="Helical"
FT                   /evidence="ECO:0000305|PubMed:26280335,
FT                   ECO:0000305|PubMed:26776682"
FT   TOPO_DOM        691..709
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:26280335,
FT                   ECO:0000305|PubMed:26776682"
FT   CARBOHYD        45
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218,
FT                   ECO:0000269|PubMed:26280335, ECO:0000269|PubMed:30598546,
FT                   ECO:0000269|PubMed:30630874, ECO:0007744|PDB:5A63,
FT                   ECO:0007744|PDB:6IDF, ECO:0007744|PDB:6IYC"
FT   CARBOHYD        55
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255, ECO:0000269|PubMed:26280335,
FT                   ECO:0000269|PubMed:30598546, ECO:0000269|PubMed:30630874,
FT                   ECO:0007744|PDB:5A63, ECO:0007744|PDB:6IDF,
FT                   ECO:0007744|PDB:6IYC"
FT   CARBOHYD        187
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218,
FT                   ECO:0000269|PubMed:26280335, ECO:0000269|PubMed:30598546,
FT                   ECO:0000269|PubMed:30630874, ECO:0007744|PDB:5A63,
FT                   ECO:0007744|PDB:6IDF, ECO:0007744|PDB:6IYC"
FT   CARBOHYD        200
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        204
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        264
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255, ECO:0000269|PubMed:26280335,
FT                   ECO:0000269|PubMed:30598546, ECO:0000269|PubMed:30630874,
FT                   ECO:0007744|PDB:5A63, ECO:0007744|PDB:6IDF,
FT                   ECO:0007744|PDB:6IYC"
FT   CARBOHYD        387
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:12754519,
FT                   ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:26280335,
FT                   ECO:0000269|PubMed:30598546, ECO:0000269|PubMed:30630874,
FT                   ECO:0007744|PDB:5A63, ECO:0007744|PDB:6IDF,
FT                   ECO:0007744|PDB:6IYC"
FT   CARBOHYD        417
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        435
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255, ECO:0000269|PubMed:26280335,
FT                   ECO:0000269|PubMed:30598546, ECO:0000269|PubMed:30630874,
FT                   ECO:0007744|PDB:5A63, ECO:0007744|PDB:6IDF,
FT                   ECO:0007744|PDB:6IYC"
FT   CARBOHYD        464
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255, ECO:0000269|PubMed:26280335,
FT                   ECO:0000269|PubMed:30598546, ECO:0000269|PubMed:30630874,
FT                   ECO:0007744|PDB:5A63, ECO:0007744|PDB:6IDF,
FT                   ECO:0007744|PDB:6IYC"
FT   CARBOHYD        506
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255, ECO:0000269|PubMed:26280335,
FT                   ECO:0000269|PubMed:30598546, ECO:0000269|PubMed:30630874,
FT                   ECO:0007744|PDB:5A63, ECO:0007744|PDB:6IDF,
FT                   ECO:0007744|PDB:6IYC"
FT   CARBOHYD        530
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255, ECO:0000269|PubMed:26280335,
FT                   ECO:0000269|PubMed:30598546, ECO:0000269|PubMed:30630874,
FT                   ECO:0007744|PDB:5A63, ECO:0007744|PDB:6IDF,
FT                   ECO:0007744|PDB:6IYC"
FT   CARBOHYD        562
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255, ECO:0000269|PubMed:26280335,
FT                   ECO:0000269|PubMed:30598546, ECO:0000269|PubMed:30630874,
FT                   ECO:0007744|PDB:5A63, ECO:0007744|PDB:6IDF,
FT                   ECO:0007744|PDB:6IYC"
FT   CARBOHYD        573
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255, ECO:0000269|PubMed:26280335,
FT                   ECO:0000269|PubMed:30598546, ECO:0000269|PubMed:30630874,
FT                   ECO:0007744|PDB:5A63, ECO:0007744|PDB:6IDF,
FT                   ECO:0007744|PDB:6IYC"
FT   CARBOHYD        580
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:30630874,
FT                   ECO:0007744|PDB:6IYC"
FT   CARBOHYD        612
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19349973"
FT   DISULFID        50..62
FT                   /evidence="ECO:0000269|PubMed:26280335,
FT                   ECO:0000269|PubMed:26623517, ECO:0000269|PubMed:30598546,
FT                   ECO:0000269|PubMed:30630874, ECO:0000305|PubMed:25043039,
FT                   ECO:0000305|PubMed:25918421, ECO:0007744|PDB:4UIS,
FT                   ECO:0007744|PDB:5A63, ECO:0007744|PDB:5FN2,
FT                   ECO:0007744|PDB:5FN3, ECO:0007744|PDB:5FN4,
FT                   ECO:0007744|PDB:5FN5, ECO:0007744|PDB:6IDF,
FT                   ECO:0007744|PDB:6IYC"
FT   DISULFID        140..159
FT                   /evidence="ECO:0000269|PubMed:26280335,
FT                   ECO:0000269|PubMed:26623517, ECO:0000269|PubMed:30598546,
FT                   ECO:0000269|PubMed:30630874, ECO:0007744|PDB:5A63,
FT                   ECO:0007744|PDB:5FN2, ECO:0007744|PDB:5FN3,
FT                   ECO:0007744|PDB:5FN4, ECO:0007744|PDB:5FN5,
FT                   ECO:0007744|PDB:6IDF, ECO:0007744|PDB:6IYC"
FT   DISULFID        195..213
FT                   /evidence="ECO:0000269|PubMed:26280335,
FT                   ECO:0000269|PubMed:26623517, ECO:0000305|PubMed:25918421,
FT                   ECO:0007744|PDB:4UIS, ECO:0007744|PDB:5A63,
FT                   ECO:0007744|PDB:5FN2, ECO:0007744|PDB:5FN3,
FT                   ECO:0007744|PDB:5FN4, ECO:0007744|PDB:5FN5"
FT   DISULFID        230..248
FT                   /evidence="ECO:0000269|PubMed:26280335,
FT                   ECO:0000269|PubMed:26623517, ECO:0000269|PubMed:30598546,
FT                   ECO:0000269|PubMed:30630874, ECO:0000305|PubMed:25918421,
FT                   ECO:0007744|PDB:4UIS, ECO:0007744|PDB:5A63,
FT                   ECO:0007744|PDB:5FN2, ECO:0007744|PDB:5FN3,
FT                   ECO:0007744|PDB:5FN4, ECO:0007744|PDB:5FN5,
FT                   ECO:0007744|PDB:6IDF, ECO:0007744|PDB:6IYC"
FT   DISULFID        586..620
FT                   /evidence="ECO:0000269|PubMed:26280335,
FT                   ECO:0000269|PubMed:26623517, ECO:0000269|PubMed:30598546,
FT                   ECO:0000269|PubMed:30630874, ECO:0007744|PDB:5A63,
FT                   ECO:0007744|PDB:5FN2, ECO:0007744|PDB:5FN3,
FT                   ECO:0007744|PDB:5FN4, ECO:0007744|PDB:5FN5,
FT                   ECO:0007744|PDB:6IDF, ECO:0007744|PDB:6IYC"
FT   VAR_SEQ         1..20
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_008385"
FT   VAR_SEQ         21..29
FT                   /note="LSFCVLLAG -> MDFNLILES (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_008386"
FT   VARIANT         75
FT                   /note="V -> I (in dbSNP:rs12045198)"
FT                   /id="VAR_050274"
FT   VARIANT         77
FT                   /note="E -> D (in dbSNP:rs35603924)"
FT                   /id="VAR_050275"
FT   VARIANT         211
FT                   /note="P -> R (in ACNINV1)"
FT                   /evidence="ECO:0000269|PubMed:21495993"
FT                   /id="VAR_067756"
FT   MUTAGEN         336..337
FT                   /note="DY->AA: Increases production of amyloid-beta
FT                   (beta-APP40 and beta-APP42) in APP processing."
FT                   /evidence="ECO:0000269|PubMed:10993067"
FT   MUTAGEN         653
FT                   /note="W->A,F: No effect on gamma-secretase activity."
FT                   /evidence="ECO:0000269|PubMed:30598546"
FT   CONFLICT        657
FT                   /note="R -> H (in Ref. 6; AAH47621)"
FT                   /evidence="ECO:0000305"
FT   HELIX           37..39
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          42..44
FT                   /evidence="ECO:0007829|PDB:6IDF"
FT   STRAND          46..49
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          59..61
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          69..76
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          78..80
FT                   /evidence="ECO:0007829|PDB:6IDF"
FT   HELIX           81..86
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          93..99
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   TURN            100..102
FT                   /evidence="ECO:0007829|PDB:5A63"
FT   HELIX           105..113
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          117..124
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          139..142
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   HELIX           143..145
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          150..152
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   HELIX           154..156
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          159..161
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   HELIX           171..173
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          174..178
FT                   /evidence="ECO:0007829|PDB:5A63"
FT   STRAND          180..183
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   HELIX           186..199
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   HELIX           203..205
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          212..218
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          220..222
FT                   /evidence="ECO:0007829|PDB:5A63"
FT   HELIX           227..239
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          240..243
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          248..250
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          253..261
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          265..267
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          271..273
FT                   /evidence="ECO:0007829|PDB:5A63"
FT   STRAND          275..281
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          287..290
FT                   /evidence="ECO:0007829|PDB:6LR4"
FT   TURN            295..298
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   HELIX           299..313
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          316..318
FT                   /evidence="ECO:0007829|PDB:6IDF"
FT   STRAND          322..331
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   TURN            334..336
FT                   /evidence="ECO:0007829|PDB:7D8X"
FT   HELIX           338..348
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          352..354
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          356..365
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          374..379
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   HELIX           383..386
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   HELIX           388..404
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   HELIX           405..407
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          412..414
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          417..419
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   HELIX           427..433
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          437..443
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          445..447
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   TURN            451..454
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   TURN            460..464
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   HELIX           473..476
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   HELIX           482..501
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   HELIX           508..510
FT                   /evidence="ECO:0007829|PDB:7D8X"
FT   HELIX           515..526
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          529..532
FT                   /evidence="ECO:0007829|PDB:5A63"
FT   HELIX           534..536
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   HELIX           540..545
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          557..560
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   HELIX           562..575
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          577..579
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   HELIX           583..587
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   HELIX           589..591
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          592..594
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   TURN            597..599
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          600..605
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   TURN            611..614
FT                   /evidence="ECO:0007829|PDB:5A63"
FT   STRAND          619..623
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          626..630
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   HELIX           633..635
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   TURN            636..638
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          643..645
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          649..651
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          652..654
FT                   /evidence="ECO:0007829|PDB:6IDF"
FT   STRAND          657..663
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   HELIX           666..692
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   HELIX           694..697
FT                   /evidence="ECO:0007829|PDB:6IYC"
FT   STRAND          698..700
FT                   /evidence="ECO:0007829|PDB:2N7R"
FT   HELIX           704..706
FT                   /evidence="ECO:0007829|PDB:2N7Q"
SQ   SEQUENCE   709 AA;  78411 MW;  C8C0EAEAD89E976A CRC64;
     MATAGGGSGA DPGSRGLLRL LSFCVLLAGL CRGNSVERKI YIPLNKTAPC VRLLNATHQI
     GCQSSISGDT GVIHVVEKEE DLQWVLTDGP NPPYMVLLES KHFTRDLMEK LKGRTSRIAG
     LAVSLTKPSP ASGFSPSVQC PNDGFGVYSN SYGPEFAHCR EIQWNSLGNG LAYEDFSFPI
     FLLEDENETK VIKQCYQDHN LSQNGSAPTF PLCAMQLFSH MHAVISTATC MRRSSIQSTF
     SINPEIVCDP LSDYNVWSML KPINTTGTLK PDDRVVVAAT RLDSRSFFWN VAPGAESAVA
     SFVTQLAAAE ALQKAPDVTT LPRNVMFVFF QGETFDYIGS SRMVYDMEKG KFPVQLENVD
     SFVELGQVAL RTSLELWMHT DPVSQKNESV RNQVEDLLAT LEKSGAGVPA VILRRPNQSQ
     PLPPSSLQRF LRARNISGVV LADHSGAFHN KYYQSIYDTA ENINVSYPEW LSPEEDLNFV
     TDTAKALADV ATVLGRALYE LAGGTNFSDT VQADPQTVTR LLYGFLIKAN NSWFQSILRQ
     DLRSYLGDGP LQHYIAVSSP TNTTYVVQYA LANLTGTVVN LTREQCQDPS KVPSENKDLY
     EYSWVQGPLH SNETDRLPRC VRSTARLARA LSPAFELSQW SSTEYSTWTE SRWKDIRARI
     FLIASKELEL ITLTVGFGIL IFSLIVTYCI NAKADVLFIA PREPGAVSY
//
